IRD vs KEY · rev $11.0M vs P/E 13, rev $7.51B
Opus Genetics, Inc. (IRD) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
IRD currently screens at market cap $35.7M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the IRD and KEY stock pages for the full models.
Not investment advice.